The abstract is read at the publisher; the summary is JClub's.
The recurrent intronic SEPSECS c.388+3A>G variant in three affected individuals from two Acadian families causes aberrant splicing with exon 3 skipping and a leaky residual transcript.
- Why it matters: Intronic splice-altering variants in SEPSECS-related PCH2D are poorly characterized, and no Acadian founder allele has been established, limiting accurate diagnosis in this ultra-rare disorder.
- What they did: The team combined exome sequencing with transcriptomic RNA analyses of patient-derived samples from three affected individuals, assessing splicing outcomes for the c.388+3A>G variant.
- The result: RNA studies showed an out-of-frame, loss-of-function–consistent transcript plus residual normally spliced transcript in blood, supporting pathogenic reclassification and a molecular diagnosis of PCH2D with an attenuated clinical course.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.